About Bell Pharma
Bell Pharma is a Healthcare company. Pharmaceutical company specializing in ophthalmic and ENT products in India. The company has 25 employees. Its Indian entity Bell Pharma Private Limited reported revenue of ₹3.79 Cr. Bell Pharma offers products and services including Ophthalmic Products and ENT Products. Its focus areas include Pharmaceuticals, ENT Products, Ear and Nose Care and Ophthalmic Products.
Company details
Bell Pharma Pvt. Ltd. is recognized as an India-based pharmaceutical company that was founded in 1958 and headquartered in Mumbai. It is specialized in the development and manufacturing of ophthalmic and ENT products, where a focus is placed on advancing healthcare through innovative services. High-quality products are provided for prevention, diagnosis, treatment, and cure, supported by integrated RD and modern manufacturing facilities that ensure flawless production and adherence to quality standards. The company is committed to enhancing global healthcare outcomes.
- Employees 25
- SectorsHealthcare
- Email••••••••
- Legal Name Bell Pharma Pvt. Ltd
- Date of Incorporation 30 Mar, 1983
- Jurisdiction Mumbai, Maharashtra, India
- Indian entity revenue₹3.79 Cr
FY 2025 · -6% YoY
- Indian entity net profit₹4.2 Lakh
FY 2025 · 1% margin
- Indian entity EBITDA₹21 Lakh
FY 2025 · 6% margin
- Employee Count25
Associated legal entities of Bell Pharma
Bell Pharma operates through Bell Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Bell Pharma Private Limited CIN U99999MH1983PTC029667 | Active | 30 Mar 1983 | Mumbai, Maharashtra | ₹3.8 Cr | 25 | 5 | View details |
Products & Services of Bell Pharma
Bell Pharma offers a comprehensive portfolio of products and services, including Ophthalmic Products and ENT Products.
Ophthalmic products are developed and manufactured for eye care treatments, including drops and ointments for various conditions
ENT products are provided for ear, nose, and throat care, encompassing solutions and drops that support medical applications
Board of directors of Bell Pharma Private Limited (Bell Pharma)
Bell Pharma Private Limited is the primary company behind Bell Pharma. The board of Bell Pharma Private Limited currently have 5 directors; the longest-serving is Sunil Damodar Paithankar, appointed in 1983.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sunil Damodar Paithankar DIN 06555352 | Director | 30 Mar 1983 | 43 yrs 6 mo | Bell Pharma Private Limited |
| Uttara Damodar Paithankar DIN 01331023 | Director | 01 Jul 1994 | 32 yrs 3 mo | Bell Pharma Private Limited |
| Mangesh Manohar Shukla DIN 01330952 | Director | 01 Jul 1994 | 32 yrs 3 mo | Bell Pharma Private Limited |
| Yashodhan Mangesh Shukla DIN 03527015 | Whole-time director | 01 Oct 2010 | 16 yrs | Bell Pharma Private Limited |
| Dhananjay Mangesh Shukla DIN 03525449 | Whole-time director | 01 Oct 2010 | 16 yrs | Bell Pharma Private Limited |
Financials of Bell Pharma
Figures of Bell Pharma Private Limited, the primary company behind Bell Pharma, for FY 2025. Revenue was ₹3.79 Cr (-6% year on year). Net profit was ₹4.2 Lakh (1% margin). EBITDA was ₹21 Lakh (6% margin). Revenue has grown at a compounded annual rate of +8% over three years and 0% over five years.
- ₹3.79 CrRevenue · FY 2025 · -6% YoY
- ₹4.2 LakhNet profit · 1% margin
- ₹21 LakhEBITDA · 6% margin
- ₹1 LakhPaid-up capital
- 25Employees (provident fund records)
- +8%Revenue CAGR, 3 years
- 0%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Bell Pharma Private Limited are on its company page.
Detailed financial statements for Bell Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bell Pharma
Bell Pharma has 25 employees.
The primary company behind Bell Pharma, Bell Pharma Private Limited, reported revenue of ₹3.79 Cr for FY 2025, down 6% year on year.
Bell Pharma Pvt. Ltd. is recognized as an India-based pharmaceutical company that was founded in 1958 and headquartered in Mumbai. It is specialized in the development and manufacturing of ophthalmic and ENT products, where a focus is placed on advancing healthcare through innovative services. High-quality products are provided for prevention, diagnosis, treatment, and cure, supported by integrated RD and modern manufacturing facilities that ensure flawless production and adherence to quality standards. The company is committed to enhancing global healthcare outcomes.
Bell Pharma offers Ophthalmic Products and ENT Products.
Bell Pharma operates through Bell Pharma Private Limited.
The legal entities of Bell Pharma currently have 5 directors, including Sunil Damodar Paithankar, Yashodhan Mangesh Shukla, Uttara Damodar Paithankar and others.